Results 21 to 30 of about 61,026 (203)

A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion. [PDF]

Clin Case Rep, 2015
We show the long-term efficacy and safety of modified biliopancreatic diversion for the treatment of LPL-deficiency. How this option compares with gene therapy is difficult to evaluate due to limited experience.
Nosso G, Capaldo B, Cocozza S, Vaccaro O.   +3 more
europepmc   +2 more sources

Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels [PDF]

, 2015
BACKGROUND: Free fatty acid (FFA) levels are raised in obesity as a consequence of increased production and reduced clearance. They may link obesity with insulin resistance.
Bellantone, Rocco Domenico Alfonso, Raffaelli, Marco, Nanni, Giuseppe, Mingrone, Geltrude, Iaconelli, Amerigo, Callari, Cosimo, Guidone, Caterina   +6 more
core   +1 more source

Jejunal adenocarcinoma after biliopancreatic diversion. Report of a case

, 2022
The effects of bariatric surgery on the development of gastrointestinal cancers remain ill defined. We present a case of jejunal adenocarcinoma developing 19 years after biliopancreatic diversion (BPD) procedure according to Scopinaro's technique.
Cossu M. L., Sogos S., Ginesu G. C., Porcu A., Fancellu A., Feo C. F., Ariu M. L.   +6 more
core   +1 more source

Bilio-pancreatic diversion: report of a case involving bone metabolism complications

Journal of International Medical Research, 2020
Prolonged vitamin D deficiency may result in lower calcium absorption and osteoporosis, leading to pathologic fractures. We report the case of a young woman with severe, complicated osteoporosis, which developed several years after biliopancreatic ...
Lidia Santarpia, Enza Speranza, Maria Laura Santopaolo, Maurizio Marra, Fabrizio Pasanisi   +4 more
doaj   +1 more source

Allele a of the rs16147 variant of neuropeptide Y predicts early metabolic improvements after bariatric surgery with biliopancreatic diversion in morbid obese subjects

Clinical Nutrition Open Science, 2021
s u m m a r y: Background and aims: Few studies have assessed the effect of rs16147 on metabolic response after weight loss interventions. We evaluated the effect of the genetic variant rs16147 NPY gene on biochemical changes after biliopancreatic ...
David Pacheco, Olatz Izaola, David Primo, Daniel de Luis   +3 more
doaj   +1 more source

Refeeding Syndrome: An Important Complication Following Obesity Surgery

Obesity Facts, 2016
Background: Refeeding syndrome (RFS) is an important and well-known complication in malnourished patients, but the incidence of RFS after obesity surgery is unknown and the awareness of RFS in obese patients as a postsurgical complication must be raised.
Sonja Chiappetta, Jürgen Stein
doaj   +1 more source

Lipid metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after biliopancreatic diversion in Hess-Marceau modification at the early stages of follow-up

Ожирение и метаболизм, 2016
Objectives: To study the lipid metabolism and secretion of GLP-1 and GIP in obese patients with type 2 diabetes before and 3 months after biliopancreatic diversion (BPD) in Hess-Marceau modification.Materials and methods: 22 patients (44 [38.0; 55.0 ...
Ekaterina Ershova, Ekaterina Troshina, Yury Yashkov   +2 more
doaj   +1 more source

Can we abandon foregut exclusion for an ideal and safe metabolic surgery?

Frontiers in Endocrinology, 2022
Foregut (foregut exclusions) and hindgut (rapid transit of nutrients to the distal intestine) theories are the most commonly used explanations for the metabolic improvements observed after metabolic surgeries.
Jason Widjaja, Yuxiao Chu, Jianjun Yang, Jian Wang, Yan Gu   +4 more
doaj   +1 more source

Characteristics of carbohydrate metabolism in the surgical treatment of morbid obesity and type 2 diabetes mellitus using various modifications of biliopancreatic diversion with duodenal switch

Сахарный диабет, 2022
BACKGROUND: Biliopancreatic diversion (BPD), and its modifications, is the most effective surgical bariatric treatment of morbid obesity and associated metabolic disturbances.
V. M. Anohina, N. S. Bordan, Yu. I. Yashkov, A. S. Orlova   +3 more
doaj   +1 more source

Glycemia normalization in patients with obesity and type 2 diabetes mellitus: bariatric surgery vs pharmacological therapy [PDF]

Терапевтический архив, 2019
Aims. To compare glucose - lowering and weight reduction capacity of bypass operations (gastric bypass (GB), biliopancreatic diversion (BPD) vs GLP-1 agonist liraglutide 3.0 mg (models of maximum incretin effect) for 6 months. Materials and methods.
I A Sklyanik, E A Shestakova, A V Yurasov, Yu I Yashkov, M V Shestakova   +4 more
doaj   +1 more source